Investing Profile

James Healy

InvestorVC
Managing Partner at Financial Services, Financial Technology, and Business Services
sofinnova.com/team/james-heal...Menlo Park, California
Photo of James Healy, Managing Partner at Financial Services, Financial Technology, and Business Services
Your Intro Paths to James Healy

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks James is a member of
Stanford University Network
1395 CONNECTIONS
University of California, Berkeley Network
751 CONNECTIONS
University of California, Berkeley Network
751 CONNECTIONS
Financial Services, Financial Technology, and Business Services Network
258 CONNECTIONS
Financial Services, Financial Technology, and Business Services Network
258 CONNECTIONS

Find James Healy on

cb
Current Investing Position
Financial Services, Financial Technology, and Business Services Managing Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
35

James Healy is on these Sector & Stage Rankings

James Healy's Investments On Record (19)

CompanyStageDateRound SizeTotal Raised
Seaport Therapeutics
Series AApr 2024$100M
$330M
Co-investors: Robert Nelsen (ARCH Venture Partners), Brett Zbar (General Atlantic)
BioAge Labs
Series DFeb 2024$170M
$290M
Co-investors: Vijay Pande (Andreessen Horowitz), Ling Wong (Sea Lane Ventures), Elad Gil (Gil Capital / Gil & Co)
Rapport Therapeutics
Series BAug 2023$150M
$250M
Co-investors: Steve Paul (Third Rock Ventures), Reid Huber (Third Rock Ventures), Sanjay Mistry (Johnson & Johnson Innovation)
ArriVent
Series BDec 2022$160M
$160M
Co-investors: Elena Viboch (General Catalyst), Carl Gordon (OrbiMed Advisors)
CinCor Pharma
Series BOct 2021$140M
Series AMay 2019$50M
$190M
Co-investors: Maina Bhaman (Sofinnova Partners), David Allison (Westlake Village BioPartners)
Karuna Therapeutics
Series BMar 2019$68M
$110M
Co-investors: Robert Nelsen (ARCH Venture Partners), Heather Preston (Oxonian Ventures ), Steve Paul (Third Rock Ventures)
ObsEva
Post Ipo EquityOct 2017$60M
Series BNov 2015$59M
Series AAug 2013$34M
$150M
Co-investors: Ed Mathers (New Enterprise Associates (NEA))
Iterum Therapeutics
Series AMar 2016$40M
$110M
Co-investors: Brent Ahrens (Canaan Partners), Patrick Heron (Frazier Healthcare Partners), Shahzad Malik (Advent Life Sciences), Mark Chin (Jmi Equity), Tracy Saxton (Dolby Family Ventures)

James Healy's Experience

Board Member InterMunePresent
Board Member Financial Services, Financial Technology, and Business ServicesPresent
Board Member Movetis NVPresent
Chairman of the Board Financial Services, Financial Technology, and Business ServicesPresent
Board Member NextWave Pharmaceuticals Inc.Present
Board Member Gedeon Richter - PregLem S.A.Present
Board Member Amarin CorporationPresent
Board Member Screenbid Media Company, LLC.Present
Board Member Coherus OncologyPresent
Board Member NuCana plcPresent
Board Member NateraPresent
Board Member Ascendis PharmaPresent
Board Observer, Audentes Therapeutics Astellas PharmaPresent
Board Observer Financial Services, Financial Technology, and Business ServicesPresent
Chairman Of The Board CinCor Pharma, Inc.Present
Board Member Karuna TherapeuticsPresent
Board Member, Lead Independent Director Bolt Biotherapeutics, Inc.Present
Managing Partner Financial Services, Financial Technology, and Business ServicesPresent

James Healy's Education

University of California, Berkeley Bachelors Scandinavian Studies
University of California, Berkeley Bachelors Molecular Biology
Stanford University PhD Immunology
Stanford University School of Medicine MD Medicine

Investors who invest with James Healy

Sign in with Google →

Scouts & Angels Affiliated With James Healy

Sign in with Google →